How can we improve outcomes for esophageal cancer?
Editorial

How can we improve outcomes for esophageal cancer?

The radical treatment of esophageal cancer includes an esophagectomy (1). Historically, this procedure is associated to a high index of morbidity and mortality. Earlam and Cunha Mello, in his classical review in 1980, calculated a mean mortality of 33% for an esophagectomy (2). This figure certainly improves due to a better understanding of perioperative physiology and advances in equipment and drugs. Modernly; however, the index is still imperfect. Mean rates as high as 11% are still reported (3).

Apart from morbidity and mortality, survival after esophagectomy for cancer is still dismal. Most series show that less than half of the patients will endure 5 years after an esophagectomy (4).

Low et al. in a landmark and prized paper (5) pointed out that results of esophagectomy for cancer has typically focused on the surgical team and issues such as mortality, complications and length of stay but there is no much more than can be done with a scalpel. Surgeons must also learn about perioperative care to improve outcomes. This motivated this Annals of Esophagus special issue on how we can improve outcomes for esophageal cancer. We invited a team of worldwide experts on the topic to review the best care to achieve better results in the treatment of esophageal cancer. Subjects include papers from the preparation for an esophagectomy with implementation of standardized clinical pathways by Dr. Low and his experienced team from the Virginia Mason Medical Center in Seattle, USA and simulation by Dr. Schlottmann from Buenos Aires, Argentina; to the application of robotic surgery by Drs. Domene and Volpe from São Paulo, Brazil; passing through specific topics such as the operation in obese patients, as reviewed by Dr. Molena and her team from the esteemed Memorial Sloan-Kettering Cancer Center.

We hope this issue will be valuable to not only surgeons but also all professionals, medical and non-medical, involved in the care of patients with esophageal cancer.


Acknowledgments

Funding: None.


Footnote

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/aoe.2020.03.02). The series “How Can We Improve Outcomes for Esophageal Cancer?” was commissioned by the editorial office without any funding or sponsorship. FAH, RMLN and RCK served as the unpaid Guest Editors of the series.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet. 2017;390:2383-96. [Crossref] [PubMed]
  2. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381-90. [Crossref] [PubMed]
  3. Fuchs HF, Harnsberger CR, Broderick RC, et al. Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. Surg Endosc 2017;31:2491-7. [Crossref] [PubMed]
  4. So B, Marcu L, Olver I, et al. Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Crit Rev Oncol Hematol 2017;113:135-50. [Crossref] [PubMed]
  5. Low DE, Kunz S, Schembre D, et al. Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg 2007;11:1395-402; discussion 1402. [Crossref] [PubMed]
Fernando A. M. Herbella
Rafael C. Katayama
Rafael Melillo Laurino Neto

Fernando A. M. Herbella, MD

(Email: herbella.dcir@epm.br)

Rafael C. Katayama, MD

(Email: rafaelcaue@hotmail.com)

Rafael Melillo Laurino Neto, MD

(Email: rmelillo@uol.com.br)

Department of Surgery, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.

Received: 01 March 2020; Accepted: 12 March 2020; Published: 25 June 2020.

doi: 10.21037/aoe.2020.03.02

doi: 10.21037/aoe.2020.03.02
Cite this article as: Herbella FAM, Katayama RC, Laurino Neto RM. How can we improve outcomes for esophageal cancer? Ann Esophagus 2020;3:10.